Post categorized under: Cannabis
With the Cannabis and agriculture industry increasingly competitive for labs, growers and processors, new innovation and improved practices can be the difference in delivering ROI and outlasting competitors. PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for a cleaner Cannabis future. Here are the issues Cannabis faces now, with insights to help us all compete and win.
- Florida Marijuana Testing Labs Under Fire as Industry Tackles Potency Problem
The issues of inflated THC potency results and lab shopping are plaguing states with large industries, including the Florida Marijuana industry. The situation has created a public mistrust of cannabis testing labs as well as a trend among marijuana businesses to shop for labs that will give them favorable test results.
- The Cannabis Regulation Crossroads in Massachusetts
The first five years of recreational Cannabis regulation in Massachusetts revealed a handful of problems. The industry is not diverse and equitable, and cities and towns have unethically taken advantage of the regulatory leverage they can hold over marijuana businesses. The state expects to reopen its regulations for additions, subtractions and revisions sometime later this year, as the industry has many wrongs to right.
- Many California Cannabis Companies Inflate THC Numbers: Here’s How They Can Stop Them
California’s state Cannabis & Hemp regulations and consumer habits emphasize the importance of THC content of Cannabis products. This has encouraged those California Cannabis companies with bad intentions to manipulate lab results and sell their products at a higher price.
- Minnesota Legalizes Adult-Use Recreational Cannabis
The new law modifies Minnesota’s list of controlled substances to exclude “industrial hemp” products that contain no more than 0.3% of any form of THC. That change brought Minnesota law in line with federal law. However, the law also allows Minnesota businesses to sell edible and drinkable products containing no more than five milligrams of THC per serving and no more than 50 milligrams of THC per package to people ages 21 and older.
- New York Cannabis Testing Regulations Approved
Cannabis testing labs in New York will need to ensure adult-use Cannabis products are not contaminated with pesticides, heavy metals or other adulterations according to updated cannabis testing regulations. The rules will allow medical Cannabis testing labs to expand their operations to serve the adult-use market as well.
- South Dakota Updates Medical Cannabis Testing
The effect of the rules will be to add regulations on testing of medical cannabis, including creation of batches and collection of samples in South Dakota. Under the rules, Cannabis testing labs must also update the inventory tracking system daily with all samples collected and the results of all tests performed.
- Why Utah Isn’t Testing Medical Marijuana
For over a year, the state has not been pathogen testing medical marijuana for the typically tested for pathogenic bacteria. Last April, the Utah Department of Agriculture and Food suspended the requirement for pathogen-specific testing.
The short answer: due to an equipment shortage, the state said it suspended Cannabis lab testing for E.coli, salmonella and several kinds of molds that cause illness, especially among the immunocompromised.
- California to Standardize Cannabis Lab Testing to Stop ‘Laboratory Shopping’
The California Department of Cannabis Control announced plans to standardize Cannabis lab testing methods amid concerns about exaggerated potency and “lab shopping” by businesses. Somewhat troubling, the department reports marijuana businesses are choosing labs that report higher THC levels than what is actually contained in the Cannabis. At PathogenDx, we stress that accurate and honest Cannabis pathogen testing is good for the future of the industry.
- Connecticut New Cannabis Testing Regulations
A legislative committee in Connecticut signed off on new medical Cannabis testing regulations that were proposed by regulators earlier this year. The new rules would set new allowable levels Total Yeast and Mold at a limit of 100,000 colony forming units per gram and would not allow any detectable levels of Aspergillus.
- More Stringent Cannabis Lab Testing Needed in the Industry
With the increasing demand for legal Cannabis and heightened participation of various states, the need for comprehensive and rigorous Cannabis lab testing solutions has now become vital. Considering a lot of individuals use Cannabis products for medical purposes, they should have to worry about falling ill from consuming pathogenic bacteria infested Cannabis products. While there could be federal criteria for Cannabis pathogen testing prerequisite, that can’t happen just yet as cannabis isn’t legal at the federal level.
Recent Comments